Publications by authors named "David Burger"

Claim this Profile
P
Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children with HIV in the CHAPAS-4 trial.
Anne E M Kamphuis, Timo Kiezebrink, Hylke Waalewijn, Alasdair Bamford, Alexander J Szubert, David M Burger

AIDS· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects on the Growth of HIV-exposed Uninfected Infants of Initiating Dolutegravir-based Versus Efavirenz-based cART in Late Pregnancy (DolPHIN-2).
Lisa Hagens, Lisanne A H Bevers, Thokozile R Malaba, Sylvia Cornelia Nassiwa, Megan Mrubata, David M Burger

Pediatr Infect Dis J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.
Lufina Tsirizani, Hylke Waalewijn, Alexander Szubert, Veronica Mulenga, Chishala Chabala, David M Burger

Antimicrob Agents Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically based pharmacokinetic model combined with a clinical lactation study to determine doravirine concentrations in human breastmilk.
Lena van der Wekken-Pas, David Burger, Rick Greupink, Angela Colbers

Br J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial.
Lisanne A H Bevers, Gabriela Toledo, Muzamil Kisekka, Elizabeth Kaudha, Grace M Ahimbisibwe, David M Burger

EBioMedicine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confirmatory Study on Costs and Time Loss from Pre-Anesthetic Consultations for Canceled Surgeries: A Retrospective Analysis at Hannover Medical School, Germany.
Steffen B Wiegand, Anna S Heinemann, Dennis Harries, David Bürger, Lisa Thiehoff

J Clin Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial Versus Real-World Circumstances and How to Interpret Pharmacokinetic Data.
Lena van der Wekken-Pas, Fabian Weiss, Charlotte Simon-Zuber, Rena Sebisch, Carmen Wiese, David Burger

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIV.
Anne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, Alasdair Bamford, Alexander Szubert, David Burger

J Acquir Immune Defic Syndr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients in Clinical Trials are Sub-Optimally Protected for Drug-Drug Interactions: A Call for Action.
David Burger, Loek de Jong, Daphne van Dijk, Catherijne A J Knibbe, Rob Ter Heine

J Clin Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-Line Antiretroviral Therapy for Children Living with HIV in Africa.
Victor Musiime, Mutsa Bwakura-Dangarembizi, Alexander J Szubert, Vivian Mumbiro, Hilda A Mujuru, David Burger

N Engl J Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical analysis plan for the "empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia" clinical trial.
Sara Domínguez-Rodríguez, David Lora, Alfredo Tagarro, Cinta Moraleda, Álvaro Ballesteros, David Burger

Trials· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib.
Joanneke K Overbeek, Nielka P van Erp, David M Burger, Alfons A den Broeder, Stijn L W Koolen

Clin Pharmacokinet· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort.
Vita W Jongen, Ferdinand W N M Wit, Anders Boyd, Arne van Eeden, Annemarie E Brouwer, David Burger

Lancet HIV· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV.
Lena van der Wekken-Pas, Fabian Weiss, Charlotte Simon-Zuber, Rena Sebisch, Carmen Wiese, David Burger

Clin Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining Targets for Antiretroviral Drug Concentrations: A Causal Framework Illustrated With Pediatric Efavirenz Data From the CHAPAS-3 Trial.
Michael Schomaker, Paolo Denti, Andrzej Bienczak, David Burger, Iván Díaz

Pharmacoepidemiol Drug Saf· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variation on dolutegravir pharmacokinetics and relation to safety and efficacy outcomes: a systematic review.
Lisanne A H Bevers, Rebecca L Jensen, Andrew Owen, Angela Colbers, Daniel F Carr, David M Burger

Pharmacogenomics· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of age and co-medication on dolutegravir glucuronidation in paediatric patients.
Tom G Jacobs, Hylke Waalewijn, Lily Houlden, Pauline D J Bollen, Annet Nanduudu, David M Burger

Br J Clin Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV.
Lufina Tsirizani, Shaghayegh Mohsenian Naghani, Hylke Waalewijn, Alexander Szubert, Veronica Mulenga, David M Burger

J Antimicrob Chemother· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians.
David M Burger, Laura Nijboer, Mira Ghobreyal, Johan Maertens, Nicole Blijlevens

Clin Pharmacokinet· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasma.
Esther M Hollander, Nachel M C Zimmerman, Berber Piet, Michel M van den Heuvel, David M Burger

Biomed Chromatogr· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial.
Hylke Waalewijn, Roeland E Wasmann, Alasdair Bamford, Diana M Gibb, Helen M McIlleron, David M Burger

J Pediatric Infect Dis Soc· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure and development of two-class resistance.
David Burger, Eva Wttewaal, Piter Oosterhof, Janneke Stalenhoef

AIDS· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen.
Piter Oosterhof, Matthijs Van Luin, Kees Brinkman, David M Burger

AIDS· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020.
Piter Oosterhof, Ferdinand W N M Wit, Matthijs van Luin, Marc van der Valk, Kees Brinkman, David M Burger

PLoS One· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers.
Lisanne A H Bevers, Anne E M Kamphuis, L C Wendy van der Wekken-Pas, Rory Leisegang, David M Burger

Clin Pharmacokinet· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis